HyClone (GE) has been working for nearly 50 years to provide high quality animal sera products for biological research and manufacturing, through innovations in collection and processing technologies. These serum products are perfectly partnered with their wide range of classical and serum free media; buffers and process liquids for research and bioproduction.
GE Healthcare acquired Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses in 2014. GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality, and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software and IT, patient monitoring and diagnostics – to drug discovery, biopharmaceutical manufacturing technologies, and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit their website at www.gehealthcare.com